Last edition
News about "London Bioscience Innovation Centre"
Merck Shuts Down London Drug Discovery Centre, Moves R&D Focus to US
Merck has announced that it will discontinue its drug discovery operations in London, citing an increasingly challenging business environment in the UK. The company has abandoned plans to occupy the Belgrove House site at King’s Cross—which had been scheduled to open in 2027—and will relocate research activities primarily to existing sites in the USA.
London Bioscience Innovation Centre | 12/09/2025 | By Darshana | 267
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy